Health Commission approves contract for low-threshold telehealth buprenorphine program
Loading...
Summary
Commissioners approved a two-year sole-source contract with Bright Heart Health to pilot tablet-based telehealth at harm-reduction sites and other access points to expand low-threshold buprenorphine and behavioral-health services; commissioners discussed medication access, privacy and program evaluation.
The San Francisco Health Commission voted on Aug. 4 to approve a two-year, sole-source contract with Bright Heart Health to expand low-threshold telehealth for medication-assisted treatment and behavioral-health access.
DPH staff explained the contract (approximately $232,960, including contingency) and described a model that uses tablets configured to open directly into Bright Heart's virtual clinic. Judith Martin, who described the proposal to commissioners, said a nurse would perform an intake and clinicians could prescribe buprenorphine remotely; medication would be dispensed through nearby behavioral-health pharmacies or local retail pharmacies when clinic pharmacies were not open.
"This kind of very low threshold buprenorphine is what street medicine has been doing now for several years," Martin said, describing prior street-medicine efforts and partnerships with local harm-reduction providers including syringe-access centers and GLIDE.
Commissioners questioned practical barriers: how patients would receive medication after a telehealth visit, whether privacy safeguards (soundproof booths) would be provided and how naloxone would be distributed. Martin said pharmacies affiliated with the program can dispense and counsel patients and that harm-reduction sites already distribute naloxone; she noted that legal and storage constraints limit on-site dispensing at many street-based locations.
Vote and formal action: Commissioners moved and seconded the contract approval; a roll-call vote was taken and affirmative votes were recorded for the commissioners present. The clerk confirmed the item was approved and the commission moved on.
Other contracts: the monthly contracts report also included amendments and extensions for hospice services (MyTree Aides Hospice), the Asian and Pacific Islander Wellness Center (term extension and updated language), Shanti Project (continuation for breast-cancer navigation and mammography van services) and other routine contract actions; commissioners discussed service volumes and equity implications before approving the package.
What happens next: DPH staff said they will monitor uptake and outcomes (referral and retention rates) and return to the commission with implementation updates and any data on medication dispensing pathways and program reach.
